{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:59:54Z","timestamp":1792299594937,"version":"4.4.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To catalog and correlate the clinical features and mutational spectrum of neurofibromatosis type 1 (NF1) patients attending a tertiary care center in India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>NF1 patients with confirmed molecular diagnosis from 2014 to 2021 were included in the study. The molecular tests used for the diagnosis were exome sequencing, targeted gene sequencing, and Multiple Ligation Probe Assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Forty-two clinically diagnosed NF1 patients who had confirmed molecular diagnosis, which is now part of the revised diagnostic criteria, were included in the analysis. Nonsense variants were the most frequently observed (35.71%), followed by frameshift (23.8%), splice site (14.29%), deletion (11.9%), missense (9.5%), and in-frame deletions (4.76%) in our case series. Three variants (c. 5269-1G &gt; C, c. 1541_1542del AG, and c. 6853_6854insA) were identified in more than one patient, suggesting that the variants are widely distributed in the gene and lack any mutational hotspot. This study supports the previous findings that patients with the variant c. 2970_2972delAAT do not develop neurofibromas; however, it was not necessary for those with whole gene deletion to have dysmorphic features as reported by other studies. The study could not establish any correlation between the type of variants and specific clinical features. Around 28% of mutations could be identified by screening exons 14, 28, 37, 46 and intron 37 in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study will contribute to a better understanding of the phenotypic variability of neurofibromatosis patients. The variable expressivity seen in NF1 suggests that modifying genes may be involved in the development of particular clinical features in addition to NF1 mutations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ni.ni_744_22","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T04:01:48Z","timestamp":1734494508000},"page":"1174-1178","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Clinical and Molecular Profile of Neurofibromatosis Type 1 Patients Using Revised Diagnostic Criteria \u2013 A Retrospective Cohort Study"],"prefix":"10.4103","volume":"72","author":[{"given":"A","family":"Rekha","sequence":"first","affiliation":[{"name":"Department of Clinical Genetics, Christian Medical College, Vellore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.V Muhammed","family":"Sanoop","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Christian Medical College, Vellore, Tamil Nadu, India"},{"name":"Department of Biochemistry, Government Medical College, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Christian Medical College, Vellore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Chapla","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Christian Medical College, Vellore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhairavi","family":"Srinageshwari","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Christian Medical College, Vellore, Tamil Nadu, India"},{"name":"Fellow Field Neurosciences Institute Laboratory for Restorative Neurology Program in Neuroscience Central Michigan University Mount Pleasant, Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitha","family":"Barney","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Christian Medical College, Vellore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautham","family":"Arunachalam","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Christian Medical College, Vellore, Tamil Nadu, India"},{"name":"Department of Human Genetics, NIMHAMS, Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sony","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Christian Medical College, Vellore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumita","family":"Danda","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Christian Medical College, Vellore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"R1-20260424","first-page":"575","article-title":"Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"key":"R2-20260424","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"key":"R3-20260424","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: An international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"key":"R4-20260424","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/archdischild-2014-308084","article-title":"Annual review of children with neurofibromatosis type 1","volume":"101","author":"Dunning-Davies","year":"2016","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"R5-20260424","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cge.12551","article-title":"Depression among adults with neurofibromatosis type 1: Prevalence and impact on quality of life","volume":"88","author":"Cohen","year":"2015","journal-title":"Clin Genet"},{"key":"R6-20260424","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/jhg.2015.6","article-title":"NF1 single and multi-exons copy number variations in neurofibromatosis type 1","volume":"60","author":"Imbard","year":"2015","journal-title":"J Hum Genet"},{"key":"R8-20260424","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/B978-0-444-52902-2.00053-9","article-title":"Neurofibromatosis type 1 (NF1): Diagnosis and management","volume":"115","author":"Ferner","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"R9-20260424","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1212\/WNL.54.8.1646","article-title":"Use of \u201cunidentified bright objects\u201d on MRI for diagnosis of neurofibromatosis 1 in children","volume":"54","author":"DeBella","year":"2000","journal-title":"Neurology"},{"key":"R10-20260424","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archdermatol.2009.169","article-title":"Predictive value of caf\u00e9 au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1","volume":"145","author":"Nunley","year":"2009","journal-title":"Arch Dermatol"},{"key":"R11-20260424","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/cen.12541","article-title":"Maturity onset diabetes of the young in India \u2013 A distinctive mutation pattern identified through targeted next-generation sequencing","volume":"82","author":"Chapla","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R12-20260424","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum Mutat"},{"key":"R13-20260424","doi-asserted-by":"crossref","first-page":"e82.","DOI":"10.1136\/jmg.40.6.e82","article-title":"Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients","volume":"40","author":"Ars","year":"2003","journal-title":"J Med Genet"},{"key":"R14-20260424","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jmg.2009.075937","article-title":"Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions","volume":"47","author":"Mautner","year":"2010","journal-title":"J Med Genet"},{"key":"R15-20260424","doi-asserted-by":"crossref","first-page":"E1506","DOI":"10.1002\/humu.21271","article-title":"NF1 microdeletions in neurofibromatosis type 1: From genotype to phenotype","volume":"31","author":"Pasmant","year":"2010","journal-title":"Hum Mutat"},{"key":"R17-20260424","doi-asserted-by":"crossref","first-page":"e136262.","DOI":"10.1172\/jci.insight.136262","article-title":"Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry","volume":"5","author":"Tabata","year":"2020","journal-title":"JCI Insight"},{"key":"R18-20260424","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"issue":"Suppl 1","key":"R19-20260424","first-page":"S91","article-title":"Genotype-phenotype correlations in neurofibromatosis and their potential clinical use","volume":"97","author":"Bettegowda","year":"2021","journal-title":"Neurology"},{"key":"R20-20260424","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp in-frame deletion in exon 17 of the NF1 gene (c. 2970-2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R21-20260424","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ejhg.2014.210","article-title":"Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patient","volume":"23","author":"Emmerich","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"R23-20260424","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"R24-20260424","doi-asserted-by":"crossref","first-page":"892.","DOI":"10.3390\/genes10110892","article-title":"Non-coding RNA and tumor development in neurofibromatosis type 1: ANRIL Rs2151280 Is associated with optic glioma development and a mild phenotype in neurofibromatosis type 1 patients","volume":"10","author":"Tritto","year":"2019","journal-title":"Genes (Basel)"},{"key":"R25-20260424","doi-asserted-by":"crossref","first-page":"778.","DOI":"10.1016\/S2213-8587(14)70208-6","article-title":"Hypothyroidism in India: More to be done","volume":"2","author":"Bagcchi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R26-20260424","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/(SICI)1096-8628(19961230)66:4<423::AID-AJMG6>3.0.CO;2-L","article-title":"Ullrich-Turner syndrome and neurofibromatosis-1","volume":"66","author":"Schorry","year":"1996","journal-title":"Am J Med Genet"},{"key":"R27-20260424","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOP.0000000000000169","article-title":"Neurofibromatosis-related tumors: Emerging biology and therapies","volume":"27","author":"Karajannis","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"R28-20260424","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/neuonc\/nov200","article-title":"Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis","volume":"18","author":"Blakeley","year":"2016","journal-title":"Neuro Oncol"},{"key":"R29-20260424","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of Selumetinib in Neurofibromatosis Type 1\u2013Related Plexiform Neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ni.ni_744_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:18Z","timestamp":1787067618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ni.ni_744_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ni.ni_744_22","relation":{},"ISSN":["0028-3886","1998-4022"],"issn-type":[{"value":"0028-3886","type":"print"},{"value":"1998-4022","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2022-08-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}